Age-Related Macular Degeneration Clinical Trials in Dallas, Texas

4 studies are recruiting for age-related macular degeneration in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

   Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) ca…

   Stage

   Phase 2

   Ages

   50 and older

   Site

   Texas Retina Associates, Dallas, Texas

   Locations

   124 in total

   Run by

   EyeBiotech Ltd.

   See if you can join NCT07440225 on ClinicalTrials.gov

2. A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

   Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the retina - the light-sensitive part at the back of the eye. There are 2 types of AMD - wet AMD and dry AMD. The advanced s…

   Stage

   Phase 1

   Ages

   50 and older

   Site

   Retina Foundation of the Southwest, Dallas, Texas

   Locations

   20 in total

   Run by

   Astellas Institute for Regenerative Medicine

   See if you can join NCT03178149 on ClinicalTrials.gov

3. Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

   Age-related macular degeneration (AMD) is the abnormal growth of new blood vessels in the light-sensitive tissue at the back of the eye called the retina. Geographic Atrophy (GA) is an advanced form of dry AMD. The purpose of this study is to assess the adverse events and how intravitreal ABBV-6628…

   Stage

   Phase 1

   Ages

   50 and older

   Site

   Retina Foundation of the Southwest /ID# 262479, Dallas, Texas

   Locations

   5 in total

   Run by

   AbbVie

   See if you can join NCT07160179 on ClinicalTrials.gov

4. Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

   1000 participants from up to 25 international locations who are at least 50 years old with either healthy eyes or a diagnosis of Age-Related Macular Degeneration (AMD) will be consented to provide images of their eyes for a new dataset. This dataset is an important step in developing an Artificial …

   Stage

   Not phased

   Ages

   50 and older

   Site

   Retina Foundation of the Southwest, Dallas, Texas

   Locations

   14 in total

   Run by

   University of Wisconsin, Madison

   See if you can join NCT06924021 on ClinicalTrials.gov